Rhumbline Advisers 4 D Molecular Therapeutics, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 69,756 shares of FDMT stock, worth $543,399. This represents 0.0% of its overall portfolio holdings.

Number of Shares

69,756

Previous 72,933 4.36%

Holding current value

$543,399

Previous $1.53 Million 50.72%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$10.81 - $27.22 $34,343 - $86,477	-3,177 Reduced 4.36%	69,756 $754,000
Q2 2024 Aug 01, 2024	BUY	$20.93 - $30.01 $189,667 - $271,950	9,062 Added 14.19%	72,933 $1.53 Million
Q1 2024 May 09, 2024	BUY	$17.03 - $35.87 $67,268 - $141,686	3,950 Added 6.59%	63,871 $2.03 Million
Q4 2023 Feb 08, 2024	BUY	$9.76 - $21.25 $14,366 - $31,280	1,472 Added 2.52%	59,921 $1.21 Million
Q3 2023 Nov 09, 2023	BUY	$12.64 - $19.76 $119,587 - $186,949	9,461 Added 19.31%	58,449 $744,000
Q2 2023 Aug 08, 2023	BUY	$15.16 - $23.26 $22,542 - $34,587	1,487 Added 3.13%	48,988 $885,000
Q1 2023 May 11, 2023	BUY	$15.45 - $23.19 $896 - $1,345	58 Added 0.12%	47,501 $817,000
Q4 2022 Feb 14, 2023	BUY	$6.85 - $25.46 $14,179 - $52,702	2,070 Added 4.56%	47,443 $1.05 Million
Q3 2022 Nov 10, 2022	BUY	$6.96 - $11.48 $26,364 - $43,486	3,788 Added 9.11%	45,373 $365,000
Q2 2022 Aug 11, 2022	BUY	$5.68 - $15.99 $36,851 - $103,743	6,488 Added 18.49%	41,585 $290,000
Q1 2022 May 12, 2022	BUY	$13.16 - $22.64 $57,667 - $99,208	4,382 Added 14.27%	35,097 $531,000
Q4 2021 Feb 10, 2022	BUY	$19.56 - $32.94 $120,822 - $203,470	6,177 Added 25.17%	30,715 $674,000
Q3 2021 Nov 12, 2021	BUY	$22.73 - $36.04 $341,654 - $541,717	15,031 Added 158.1%	24,538 $662,000
Q2 2021 Aug 05, 2021	BUY	$22.2 - $42.29 $81,052 - $154,400	3,651 Added 62.35%	9,507 $229,000
Q1 2021 May 06, 2021	BUY	$35.94 - $52.67 $210,464 - $308,435	5,856 New	5,856 $254,000

Others Institutions Holding FDMT

# of Institutions

144

Shares Held

57.7M

Call Options Held

137K

Put Options Held

111K

View Full List

About 4D Molecular Therapeutics, Inc.

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $252M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

More about FDMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers 4 D Molecular Therapeutics, Inc. Transaction History